J. Tokunaga et al., EFFECTS OF BETAMIPRON ON CISPLATIN NEPHROTOXICITY AND ITS PHARMACOKINETICS IN RATS, Biological & pharmaceutical bulletin, 20(4), 1997, pp. 386-391
The protective effects of betamipron (BP, N-benzoyl-beta-alanine) on t
ile nephrotoxicity of cisplatin were examined as indicated by body wei
ght gain, ratio of kidney weight to body weight, blood urea nitrogen a
nd serum creatinine levels in tumor-bearing rats. The results showed c
learly that administration of BP Ih after cisplatin treatment affords
protection against the nephrotoxicity of cisplatin. Furthermore, the a
ddition of BP to cisplatin had no apparent effect on the efficacy of c
isplatin against Walker 256 carcinosarcoma cells in rats, In addition,
no observed significant difference in plasma cisplatin concentration
between cisplatin with alkaline solution and cisplatin with BP mag be
partly attributed to the decrease in the cisplatin er;sorption to the
intestine and its excretion to bile, and to an increase in cisplatin e
xcretion to the urine.